Silex Systems (SLX) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
8 Jul, 2026Opening remarks and agenda
AGM opened with confirmation of quorum and welcome to both in-person and virtual attendees.
CEO/Managing Director Dr. Michael Goldsworthy led the meeting, focusing on technology commercialisation and strategic progress.
Board members, CEO, and auditor introduced; agenda included business update and voting on resolutions.
Shareholders provided with instructions for participation, voting, and Q&A.
Financial performance review
Market capitalisation reached approximately AUD 2 billion as of October 2025, with a share price of AUD 7.47 and ~277 million shares on issue.
Balance sheet strengthened by AUD 150 million equity placement and nearly AUD 20 million share purchase plan, ensuring funding through FY 2028.
Cash and term deposits stood at AUD 210 million as of 30 September 2025, with no corporate-level debt.
Institutional shareholders accounted for about 35% of the register.
Board and executive committee updates
Board composition highlighted, including the addition of a Non-Executive Director with global mining and governance expertise.
Chris Wilks stood for reelection with full board support.
The Board authorised the release of the AGM presentation, highlighting ongoing risk management and forward-looking strategies.
Leadership praised for navigating a complex, regulated, and technology-driven environment.
Latest events from Silex Systems
- Advancing laser enrichment and quantum silicon projects, with strong US support and no debt.SLX
Investor Presentation - Net loss widened to $42.6m as SILEX commercialisation advanced and cash reserves remained strong.SLX
H2 2025 - GLE's SILEX technology targets US nuclear fuel independence with strong market and policy tailwinds.SLX
Investor presentation - Revenue doubled and cash surged after a capital raise; GLE secured a major U.S. DOE award.SLX
H1 2026 - Major technology milestone and US support position SILEX for uranium and quantum silicon growth.SLX
Investor Presentation - $145m equity raise funds SILEX laser enrichment commercialisation, targeting US nuclear fuel supply.SLX
Investor Presentation - Nuclear and quantum projects advanced, with strong cash reserves and key risks addressed.SLX
AGM 2024 - GLE pilot and Silex's diversification position the company for growth amid nuclear market shifts.SLX
H2 2024 - GLE accelerates SILEX technology for uranium, silicon, and isotope markets, targeting 2028 launch.SLX
Investor Presentation